The plasma hCAP-18 levels were reduced in patients with Shwachman-Diamond syndrome, Barth syndrome, Cohen syndrome, SGD, and acute myeloid leukaemia (AML) and similar to those of patients with SCN (Table 4 and Supplementary Fig. 1b–e). This evidence concerns the gene CAMP and Shwachman-Diamond syndrome.